Incyte
INCY
#1059
Rank
ยฃ17.21 B
Marketcap
ยฃ86.19
Share price
5.78%
Change (1 day)
73.64%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ1.30 Billion

According to Incyte's latest financial reports the company's total liabilities are ยฃ1.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ1.32 B-16.44%
2024-12-31ยฃ1.59 B27.31%
2023-12-31ยฃ1.24 B2.8%
2022-12-31ยฃ1.21 B41.07%
2021-12-31ยฃ0.86 B23.7%
2020-12-31ยฃ0.69 B10.29%
2019-12-31ยฃ0.63 B11.4%
2018-12-31ยฃ0.56 B14.05%
2017-12-31ยฃ0.49 B-49.68%
2016-12-31ยฃ0.98 B75.08%
2015-12-31ยฃ0.56 B0.06%
2014-12-31ยฃ0.56 B13.09%
2013-12-31ยฃ0.49 B59.51%
2012-12-31ยฃ0.31 B-12.6%
2011-12-31ยฃ0.35 B-4.49%
2010-12-31ยฃ0.37 B-25.61%
2009-12-31ยฃ0.50 B62.85%
2008-12-31ยฃ0.30 B41.13%
2007-12-31ยฃ0.21 B-2.14%
2006-12-31ยฃ0.22 B-1.89%
2005-12-31ยฃ0.22 B-0.07%
2004-12-31ยฃ0.22 B81.38%
2003-12-31ยฃ0.12 B-19.17%
2002-12-31ยฃ0.15 B-14.9%
2001-12-31ยฃ0.18 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
ยฃ60.31 B 4,538.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ88.81 B 6,729.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ64.69 B 4,874.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ63.12 B 4,754.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.40 B-68.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
ยฃ0.26 B-79.92%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
ยฃ0.10 B-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
ยฃ54.84 M-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ0.26 B-79.26%๐Ÿ‡บ๐Ÿ‡ธ USA